𐐜𐐨𐑆 7 𐐤𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐐂𐑉 𐑄𐐲 𐐡𐐨𐑊 𐐝𐑋𐐪𐑉𐐻 𐐔𐑉𐐲𐑀𐑆

𐐤𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐐪𐑉 𐐼𐑉𐐲𐑀𐑆, 𐑅𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐑅, 𐐲𐑌𐐼 𐑁𐐭𐐼𐑆 𐑄𐐰𐐻 𐐮𐑋𐐹𐑉𐐭𐑂 𐑋𐐯𐑌𐐻𐐲𐑊 𐑁𐐲𐑍𐐿𐑇𐐲𐑌. 𐐝𐐲𐑋𐐻𐐴𐑋𐑆 𐐹𐐨𐐹𐐲𐑊 𐑉𐐲𐑁𐐲𐑉 𐐻𐐭 𐑄𐐯𐑋 𐐰𐑆 𐑅𐑋𐐪𐑉𐐻 𐐼𐑉𐐲𐑀𐑆. 𐐜𐐩 𐑁𐐲𐑅𐐮𐑊𐐲𐐻𐐩𐐻 𐐼𐐮𐑆𐐴𐐲𐑉𐐼 𐑋𐐯𐑌𐐻𐐲𐑊 𐑁𐐲𐑍𐐿𐑇𐐲𐑌𐑆 𐑊𐐴𐐿 𐑋𐐯𐑋𐐲𐑉𐐨 𐐲𐑌𐐼 𐑁𐐬𐐿𐐲𐑅, 𐐲𐑌𐐼 𐑉𐐲𐐼𐐭𐑅 undesired 𐑋𐐯𐑌𐐻𐐲𐑊 𐑅𐐻𐐩𐐻𐑅 𐑊𐐴𐐿 𐑅𐐻𐑉𐐯𐑅 𐐲𐑌𐐼 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌.

𐐌𐑂 𐐺𐐮𐑌 𐑉𐐨𐑅𐐲𐑉𐐽𐐮𐑍 𐐲𐑌𐐼 𐐯𐐿𐑅𐐹𐐯𐑉𐐲𐑋𐐯𐑌𐐻𐐮𐑍 𐐶𐐮𐑄 𐑄𐐯𐑋 𐑁𐐫𐑉 𐐷𐐮𐑉𐑆. 𐐊𐑌𐐼 𐐌𐑂 𐑁𐐶𐑌𐐼 𐑄𐐰𐐻 𐑋𐐬𐑅𐐻 𐐼𐐬𐑌𐐻 𐑅𐐨𐑋 𐐻𐐭 𐐼𐐭 𐑋𐐲𐐽 𐑋𐐫𐑉 𐑄𐐰𐑌 𐑋𐐩𐐿 𐐮𐐿𐑅𐐹𐐯𐑌𐑅𐐮𐑂 𐐷𐐲𐑉𐐲𐑌. 𐐒𐐲𐐻 𐑄𐐯𐑉 𐐪𐑉 𐐮𐐿𐑅𐐯𐐹𐑇𐐲𐑌𐑆. 𐐒𐐮𐑊𐐬 𐐮𐑆 𐑋𐐴 𐑊𐐮𐑅𐐻 𐐲𐑂 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐑄𐐰𐐻 𐐶𐐲𐑉𐐿, 𐐺𐐩𐑅𐐻 𐐪𐑌 𐐹𐐮𐑉-𐑉𐐨𐑂𐐷𐐭𐐼 𐑅𐐴𐐲𐑌𐐻𐐮𐑁𐐮𐐿 𐑉𐐨𐑅𐐲𐑉𐐽 𐐲𐑌𐐼 𐑋𐐴 𐐬𐑌 𐐮𐐿𐑅𐐹𐐮𐑉𐐨𐐲𐑌𐑅.

1) Bacopa Monnieri

Bacopa Monnieri 𐐮𐑆 𐐲 𐐹𐐲𐑉𐐯𐑌𐐨𐐲𐑊 𐐿𐑉𐐨𐐹𐐮𐑍 𐐲𐑉𐐺 𐑌𐐩𐐻𐐮𐑂 𐐻𐐭 𐐶𐐯𐐻𐑊𐐰𐑌𐐼𐑆 𐐶𐐲𐑉𐑊𐐼𐐶𐐴𐐼. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐑋𐐯𐑋𐐲𐑉𐐨, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐰𐑍𐑆𐐴𐐲𐐻𐐨, 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌, 𐐲𐑌𐐼 𐑁𐐲𐑉𐑀𐐯𐐻𐐮𐑍.

• 𐐔𐐲𐑆 Bacopa monnieri 𐐮𐑋𐐹𐑉𐐭𐑂 𐑋𐐯𐑋𐐲𐑉𐐨 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅 𐐮𐑌 𐐬𐑊𐐼𐐲𐑉 𐐹𐐲𐑉𐑅𐐲𐑌𐑆? 𐐡𐐮𐑆𐐲𐑊𐐻𐑅 𐐲𐑂 𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼, 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐻𐑉𐐴𐐲𐑊.

• 𐐆𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 𐐲 𐑅𐐻𐐰𐑌𐐼𐐲𐑉𐐼𐐴𐑆𐐼 Bacopa monnieri 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐪𐑌 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅, 𐐰𐑍𐑆𐐴𐐲𐐻𐐨, 𐐲𐑌𐐼 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌 𐐮𐑌 𐑄𐐲 𐐯𐑊𐐼𐐲𐑉𐑊𐐨: 𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼, 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊.

• 𐐗𐑉𐐪𐑌𐐮𐐿 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 Brahmi (Bacopa monnieri) 𐐪𐑌 𐐸𐐷𐐭𐑋𐐲𐑌 𐑋𐐯𐑋𐐲𐑉𐐨.

• 𐐆𐑀𐑆𐐰𐑋𐐮𐑌𐐮𐑍 𐑄𐐲 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 𐐲 𐑅𐐹𐐯𐑇𐐲𐑊 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐲𐑂 Bacopa monniera 𐐪𐑌 𐐸𐐷𐐭𐑋𐐲𐑌 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐑁𐐲𐑍𐐿𐑇𐐲𐑌𐐮𐑍: 90 𐐼𐐩 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐻𐑉𐐴𐐲𐑊.

• 𐐡𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 𐑅𐐻𐐰𐑌𐐼𐐲𐑉𐐼𐐴𐑆𐐼 Bacopa monniera 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐮𐑌 𐐩𐐾-𐐲𐑅𐐬𐑅𐐨𐐩𐐻𐐮𐐼 𐑋𐐯𐑋𐐲𐑉𐐨 𐐮𐑋𐐹𐐯𐑉𐑋𐐲𐑌𐐻.

• 𐐜𐐲 𐐲𐐿𐐷𐐭𐐻 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 𐐰𐑌 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐲𐑂 Bacopa monniera (Brahmi) 𐐪𐑌 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐑁𐐲𐑍𐐿𐑇𐐲𐑌 𐐮𐑌 𐐸𐐯𐑊𐑃𐐨 𐑌𐐫𐑉𐑋𐐲𐑊 𐑅𐐲𐐺𐐾𐐮𐐿𐐻𐑅.

• 𐐜𐐲 𐐿𐑉𐐪𐑌𐐮𐐿 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 𐐰𐑌 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐲𐑂 Bacopa monniera (Brahmi) 𐐪𐑌 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐑁𐐲𐑍𐐿𐑇𐐲𐑌 𐐮𐑌 𐐸𐐯𐑊𐑃𐐨 𐐸𐐷𐐭𐑋𐐲𐑌 𐑅𐐲𐐺𐐾𐐮𐐿𐐻𐑅.

• Brahmi 𐑁𐐫𐑉 𐑄𐐲 𐐺𐐯𐐻𐐲𐑉? 𐐤𐐭 𐑁𐐴𐑌𐐼𐐮𐑍𐑆 𐐽𐐰𐑊𐐲𐑌𐐾𐐮𐑍 𐐿𐐪𐑀𐑌𐐮𐑇𐐲𐑌 𐐲𐑌𐐼 𐐰𐑌𐐻𐐨-𐐰𐑍𐑆𐐴𐐲𐐻𐐨 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 Brahmi (Bacopa monniera) 𐐮𐑌 𐐸𐐯𐑊𐑃𐐨 𐐲𐐼𐐲𐑊𐐻𐑅.

2) Creatine

Creatine 𐐮𐑆 𐐲 𐑌𐐴𐐻𐑉𐐪𐐾𐐲𐑌𐐲𐑅 𐐫𐑉𐑀𐐰𐑌𐐮𐐿 𐐰𐑅𐐲𐐼 𐑄𐐰𐐻 𐐲𐐿𐐲𐑉𐑆 𐑌𐐰𐐽𐐲𐑉𐐲𐑊𐐨 𐐮𐑌 𐑂𐐲𐑉𐐻𐐲𐐺𐑉𐐩𐐻𐑅. 𐐆𐐻 𐐮𐑆 𐐺𐐯𐑅𐐻 𐑌𐐬𐑌 𐑁𐐫𐑉 𐐹𐑉𐐲𐑂𐐴𐐼𐐮𐑍 𐐺𐐯𐑌𐐲𐑁𐐮𐐻𐑅 𐐻𐐭 𐐹𐐲𐑉𐑅𐐲𐑌𐑆 𐐯𐑌𐑀𐐩𐐾𐐼 𐐮𐑌 𐑅𐐻𐑉𐐯𐑍𐐿𐑃 𐐻𐑉𐐩𐑌𐐮𐑍. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑁𐐲𐐻𐐨𐑀, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌; 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐑁𐐲𐐻𐐨𐑀 𐑉𐐮𐑆𐐮𐑅𐐻𐐲𐑌𐑅, 𐑅𐐲𐐺𐐾𐐯𐐿𐐻𐐮𐑂 𐐶𐐯𐑊-𐐺𐐨𐐮𐑍, 𐐲𐑌𐐼 𐐿𐐪𐑀𐑌𐐮𐑇𐐲𐑌; 𐐲𐑌𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐑅𐑊𐐨𐐹 𐐼𐐯𐐹𐑉𐐲𐑂𐐩𐑇𐐲𐑌.

• 𐐆𐑁𐐯𐐿𐐻 𐐲𐑂 creatine 𐑅𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐐲𐑌𐐼 𐑅𐑊𐐨𐐹 𐐼𐐯𐐹𐑉𐐲𐑂𐐩𐑇𐐲𐑌, 𐐶𐐮𐑄 𐑋𐐴𐑊𐐼 𐐯𐐿𐑅𐐲𐑉𐑅𐐴𐑆, 𐐪𐑌 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐐲𐑌𐐼 psychomotor 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅, 𐑋𐐭𐐼 𐑅𐐻𐐩𐐻, 𐐲𐑌𐐼 𐐹𐑊𐐰𐑆𐑋𐐲 𐐿𐐪𐑌𐑅𐐲𐑌𐐻𐑉𐐩𐑇𐐲𐑌𐑆 𐐲𐑂 catecholamines 𐐲𐑌𐐼 𐐿𐐫𐑉𐐻𐐮𐑅𐐫𐑊.

• 𐐢𐐬 𐐼𐐬𐑅 creatine 𐑅𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐐯𐑌𐐸𐐰𐑌𐑅𐐮𐑆 𐑅𐐹𐑉𐐮𐑌𐐻 𐑁𐐩𐑆 𐐲𐑂 400 𐑋𐐨𐐻𐐲𐑉𐑆 𐑅𐐶𐐮𐑋𐐮𐑍 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅.

• 𐐑𐑉𐐨𐑂𐐯𐑌𐑇𐐲𐑌 𐐲𐑂 𐐻𐑉𐐫𐑋𐐰𐐻𐐮𐐿 𐐸𐐯𐐼𐐩𐐿, 𐐼𐐮𐑆𐐨𐑌𐐲𐑅 𐐲𐑌𐐼 𐑁𐐲𐐻𐐨𐑀 𐐶𐐮𐑄 creatine 𐐰𐐼𐑋𐐮𐑌𐐮𐑅𐐻𐑉𐐩𐑇𐐲𐑌. 𐐊 𐐹𐐴𐑊𐐲𐐻 𐑅𐐻𐐲𐐼𐐨.

• Creatine monohydrate 𐐮𐑌 𐐔𐐨𐐯𐑋2/𐐑𐐨𐐪𐑉𐐬𐐯𐑋𐐯𐑋: 𐐲 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐿𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐑅𐐻𐐲𐐼𐐨. 𐐑𐑉𐐪𐐿𐑅𐐲𐑋𐐲𐑊 myotonic myopathy.

• Creatine monohydrate 𐐮𐑌 𐐁𐐯𐑊𐐯𐑅: 𐐮𐑁𐐯𐐿𐐻𐑅 𐐪𐑌 𐑅𐐻𐑉𐐯𐑍𐐿𐑃, 𐑁𐐲𐐻𐐨𐑀, 𐑉𐐯𐑅𐐹𐐲𐑉𐐲𐐻𐐫𐑉𐐨 𐑅𐐻𐐰𐐻𐐲𐑅 𐐲𐑌𐐼 ALSFRS.

• 𐐆𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 creatine 𐐪𐑌 𐑋𐐯𐑌𐐻𐐲𐑊 𐑁𐐲𐐻𐐨𐑀 𐐲𐑌𐐼 𐑅𐐯𐑉𐐲𐐺𐑉𐐲𐑊 𐐸𐐨𐑋𐐲𐑀𐑊𐐬𐐺𐐲𐑌 𐐪𐐿𐑅𐐲𐐾𐐲𐑌𐐩𐑇𐐲𐑌.

• 𐐆𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 creatine 𐑅𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐐪𐑌 𐐪𐐿𐑅𐐲𐐼𐐴𐐻𐐮𐑂 𐑅𐐻𐑉𐐯𐑅 𐐲𐑌𐐼 𐐮𐑌𐑁𐑊𐐰𐑋𐐲𐐻𐐫𐑉𐐨 𐑋𐐪𐑉𐐿𐐲𐑉𐑆 𐐰𐑁𐐻𐐲𐑉 𐑉𐐮𐐹𐐨𐐻𐐮𐐼-𐑅𐐹𐑉𐐮𐑌𐐻 𐐯𐐿𐑅𐐲𐑉𐑅𐐴𐑆 𐐮𐑌 𐐸𐐷𐐭𐑋𐐲𐑌𐑆.

3) Ginkgo Biloba

Ginkgo Biloba 𐐮𐑆 𐐲 𐐻𐑉𐐨 𐑌𐐩𐐻𐐮𐑂 𐐻𐐭 𐐕𐐴𐑌𐐲. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐐼𐐮𐐿𐑊𐐴𐑌, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑉𐐬𐐺𐐲𐑅𐐻 𐑉𐐨𐑅𐐲𐑉𐐽 𐐿𐐲𐑌𐐼𐐲𐐿𐐻𐐲𐐼 𐐶𐐮𐑄 𐑉𐐮𐐹𐐨𐐻𐐮𐐼 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐿𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐐻𐑉𐐴𐐲𐑊𐑆. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐑋𐐯𐑋𐐲𐑉𐐨, 𐐿𐐪𐑀𐑌𐐮𐑇𐐲𐑌, 𐑅𐑊𐐨𐐹 𐐿𐐶𐐪𐑊𐐲𐐻𐐨, 𐑅𐐲𐐺𐐾𐐯𐐿𐐻𐐮𐑂 𐐶𐐯𐑊-𐐺𐐨𐐮𐑍, 𐐿𐐪𐑋𐑌𐐲𐑅, 𐑅𐐯𐑉𐐲𐐺𐑉𐐲𐑊 𐐺𐑊𐐲𐐼 𐑁𐑊𐐬, 𐐹𐑉𐐪𐑅𐐯𐑅𐐮𐑍 𐐰𐐿𐐷𐐲𐑉𐐲𐑅𐐨, 𐐹𐑉𐐪𐑅𐐯𐑅𐐮𐑍 𐑅𐐹𐐨𐐼, 𐐲𐑌𐐼 𐑉𐐨𐐰𐐿𐑇𐐲𐑌 𐐻𐐴𐑋; 𐐲𐑌𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐐈𐑊𐑆𐐸𐐴𐑋𐐲𐑉𐑆, 𐐁𐐼𐐨𐐩𐐽𐐼𐐨 𐐮𐑌 𐐽𐐮𐑊𐐼𐑉𐐲𐑌, 𐐰𐑍𐑆𐐴𐐲𐐻𐐨, 𐑌𐐭𐑋𐐯𐑉𐐲𐐿𐐲𐑊 𐑋𐐯𐑋𐐲𐑉𐐨, 𐑅𐐻𐑉𐐯𐑅, 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐐑𐐨𐐯𐑋𐐯𐑅, 𐐲𐑌𐐼 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐑅𐐿𐐮𐐻𐑅𐐲𐑁𐑉𐐨𐑌𐐨𐐲.

• 𐐢𐐫𐑍-𐐻𐐲𐑉𐑋 𐐷𐐭𐑅 𐐲𐑂 standardised Ginkgo biloba 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐑁𐐫𐑉 𐑄𐐲 𐐹𐑉𐐨𐑂𐐯𐑌𐑇𐐲𐑌 𐐲𐑂 𐐈𐑊𐑆𐐸𐐴𐑋𐐲𐑉𐑆 𐐼𐐮𐑆𐐨𐑆 (GuidAge): 𐐲 randomised 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊.

• 𐐑𐑉𐐭𐑁 𐐲𐑂 𐐯𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑂 𐑄𐐲 ginkgo biloba 𐑅𐐹𐐯𐑇𐐲𐑊 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 EGb 761 𐐮𐑌 𐐶𐐻𐐹𐐩𐑇𐐲𐑌𐐻𐑅 𐑅𐐲𐑁𐐲𐑉𐐮𐑍 𐑁𐑉𐐲𐑋 𐑋𐐴𐑊𐐼 𐐻𐐭 𐑋𐐪𐐼𐐲𐑉𐐲𐐻 𐐹𐑉𐐴𐑋𐐯𐑉𐐨 𐐼𐐮𐐾𐐯𐑌𐐲𐑉𐐲𐐻𐐮𐑂 𐐼𐐮𐑋𐐯𐑌𐑇𐐨𐐲 𐐲𐑂 𐑄𐐲 𐐈𐑊𐑆𐐸𐐴𐑋𐐲𐑉 𐐻𐐴𐐹 𐐫𐑉 𐑋𐐲𐑊𐐻𐐨-infarct 𐐼𐐮𐑋𐐯𐑌𐑇𐐨𐐲.

• 𐐊 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 tanakan 𐐮𐑌 𐑄𐐲 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐐮𐐼𐐨𐐬𐐹𐐰𐑃𐐲𐐿 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐐮𐑋𐐹𐐯𐑉𐑋𐐲𐑌𐐻 𐐮𐑌 𐑄𐐲 𐐯𐑊𐐼𐐲𐑉𐑊𐐨

• 𐐓𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐐩𐐾-𐑉𐐮𐑊𐐩𐐻𐐮𐐼 𐑋𐐯𐑋𐐲𐑉𐐨 𐐿𐐲𐑋𐐹𐑊𐐩𐑌𐐻𐑅 𐐶𐐮𐑄 Ginkgo biloba 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻: 𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐼𐐲𐐺𐐲𐑊 𐐺𐑊𐐴𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐑅𐐻𐐲𐐼𐐨.

• 𐐆𐑁𐐯𐐿𐐻 𐐲𐑂 𐐎𐐯𐑅𐐻𐐲𐑉𐑌 𐑋𐐯𐐼𐐲𐑅𐐲𐑌 𐑃𐐯𐑉𐐲𐐹𐐨 𐐲𐑅𐐮𐑅𐐻𐐮𐐼 𐐺𐐴 Ginkgo biloba 𐐻𐐰𐐺𐑊𐐲𐐻 𐐪𐑌 𐑂𐐰𐑅𐐿𐐷𐐲𐑊𐐲𐑉 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐐮𐑋𐐹𐐯𐑉𐑋𐐲𐑌𐐻 𐐲𐑂 𐑌𐐲𐑌 𐐼𐐮𐑋𐐯𐑌𐑇𐐨𐐲.

• Ginkgo biloba 𐑅𐐹𐐯𐑇𐐲𐑊 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐮𐑌 𐐼𐐮𐑋𐐯𐑌𐑇𐐨𐐲 𐐶𐐮𐑄 neuropsychiatric 𐑁𐐨𐐽𐐲𐑉𐑆. 𐐊 randomised, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼, 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐿𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐐻𐑉𐐴𐐲𐑊.

• Ginkgo biloba 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 EGb 761® 𐐮𐑌 𐐼𐐮𐑋𐐯𐑌𐑇𐐨𐐲 𐐶𐐮𐑄 neuropsychiatric 𐑁𐐨𐐽𐐲𐑉𐑆: 𐐲 randomised, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊 𐐻𐐭 𐐿𐐲𐑌𐑁𐐲𐑉𐑋 𐑄𐐲 𐐯𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑌𐐼 𐑅𐐩𐑁𐐻𐐨 𐐲𐑂 𐐲 𐐼𐐩𐑊𐐨 𐐼𐐬𐑅 𐐲𐑂 240 𐐯𐑋𐑀𐐨.

• 𐐇𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑌𐐼 tolerability 𐐲𐑂 𐐲 𐐶𐐲𐑌𐑅 𐐼𐐩𐑊𐐨 𐑁𐐫𐑉𐑋𐐷𐐲𐑊𐐩𐑇𐐲𐑌 𐐲𐑂 Ginkgo biloba 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 EGb 761® 𐐮𐑌 𐐈𐑊𐑆𐐸𐐴𐑋𐐲𐑉𐑆 𐐼𐐮𐑆𐐨𐑆 𐐲𐑌𐐼 𐑂𐐰𐑅𐐿𐐷𐐲𐑊𐐲𐑉 𐐼𐐮𐑋𐐯𐑌𐑇𐐨𐐲: 𐑉𐐮𐑆𐐲𐑊𐐻𐑅 𐑁𐑉𐐲𐑋 𐐲 randomised 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊.

• Ginkgo biloba 𐑁𐐫𐑉 𐐹𐑉𐐮𐑂𐐯𐑌𐐻𐐮𐑍 𐐿𐐪𐑀𐑌𐐮𐐻𐐮𐑂 𐐼𐐮𐐿𐑊𐐴𐑌 𐐮𐑌 𐐬𐑊𐐼𐐲𐑉 𐐲𐐼𐐲𐑊𐐻𐑅: 𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐻𐑉𐐴𐐲𐑊.

• Ginkgo biloba 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 EGb 761(𐐂𐑉), donepezil 𐐫𐑉 𐐺𐐬𐑃 𐐿𐐲𐑋𐐺𐐴𐑌𐐼 𐐮𐑌 𐑄𐐲 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐐈𐑊𐑆𐐸𐐴𐑋𐐲𐑉𐑆 𐐼𐐮𐑆𐐨𐑆 𐐶𐐮𐑄 neuropsychiatric 𐑁𐐨𐐽𐐲𐑉𐑆: 𐐲 randomised, 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐐮𐐿𐑅𐐹𐑊𐐫𐑉𐐲𐐻𐐫𐑉𐐨 𐐻𐑉𐐴𐐲𐑊.

4) Inositol

Inositol 𐐮𐑆 𐐲 𐑇𐐳𐑀𐐲𐑉 𐐰𐑊𐐿𐐲𐐸𐐪𐑊 𐐿𐐯𐑋𐐲𐐿𐐲𐑊 𐐿𐐪𐑋𐐹𐐶𐑌𐐼 𐑄𐐰𐐻 𐐮𐑀𐑆𐐮𐑅𐐻𐑅 𐐮𐑌 𐑂𐐯𐑉𐐨𐐲𐑅 𐑁𐐫𐑉𐑋𐑆, 𐑄𐐲 𐑋𐐬𐑅𐐻 𐐹𐑉𐐪𐑋𐐲𐑌𐐲𐑌𐐻 𐐲𐑂 𐐶𐐮𐐽 𐐮𐑆 myo-inositol, 𐐶𐐮𐐽 𐐲𐐿𐐲𐑉𐑆 𐐶𐐴𐐼𐑊𐐨 𐐮𐑌 𐑌𐐩𐐽𐐲𐑉. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐰𐑍𐑆𐐴𐐲𐐻𐐨 𐐲𐑌𐐼 𐐹𐐰𐑌𐐮𐐿 𐐲𐐻𐐰𐐿𐑅, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌, 𐐲𐑌𐐼 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐐑𐐨𐐯𐑋𐐯𐑅.

• 𐐔𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼, 𐐿𐑉𐐫𐑅𐐬𐑂𐐲𐑉 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 inositol 𐑂𐐲𐑉𐑅𐐲𐑅 fluvoxamine 𐑁𐐫𐑉 𐑄𐐲 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐐹𐐰𐑌𐐮𐐿 𐐼𐐮𐑅𐐫𐑉𐐼𐐲𐑉.

• 𐐔𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼, 𐐿𐑉𐐫𐑅𐐬𐑂𐐲𐑉 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 inositol 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐑁𐐫𐑉 𐐹𐐰𐑌𐐮𐐿 𐐼𐐮𐑅𐐫𐑉𐐼𐐲𐑉.

• Inositol 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐐲𐐺𐑅𐐯𐑅𐐮𐑂-𐐿𐐲𐑋𐐹𐐲𐑊𐑅𐐮𐑂 𐐼𐐮𐑅𐐫𐑉𐐼𐐲𐑉.

• 𐐆𐑁𐐯𐐿𐐻 𐐲𐑂 inositol 𐐪𐑌 𐐺𐐷𐐭𐑊𐐮𐑋𐐨𐐲 𐑌𐐲𐑉𐑂𐐬𐑅𐐲 𐐲𐑌𐐼 𐐺𐐮𐑌𐐾 𐐨𐐻𐐮𐑍.

• 𐐊𐐿𐐷𐐭𐐻 inositol 𐐼𐐲𐑆 𐑌𐐪𐐻 𐐲𐐻𐐯𐑌𐐷𐐭𐐩𐐻 𐐯𐑋-𐐝𐐨𐐹𐐨𐐹𐐨-𐐮𐑌𐐼𐐭𐑅𐐻 𐐰𐑍𐑆𐐴𐐲𐐻𐐨, mydriasis 𐐲𐑌𐐼 𐐯𐑌𐐼𐐬𐐿𐑉𐐴𐑌 𐐮𐑁𐐯𐐿𐐻𐑅 𐐮𐑌 𐐹𐐰𐑌𐐮𐐿 𐐼𐐮𐑅𐐫𐑉𐐼𐐲𐑉.

5) 𐐣𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌

𐐣𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌 𐐮𐑆 𐐲 𐑅𐐲𐐺𐑅𐐻𐐲𐑌𐑅 𐑁𐐶𐑌𐐼 𐐮𐑌 𐐰𐑌𐐲𐑋𐐲𐑊𐑆, 𐐹𐑊𐐰𐑌𐐻𐑅, 𐑁𐐲𐑌𐐾𐐴, 𐐲𐑌𐐼 𐐺𐐰𐐿𐐻𐐮𐑉𐐨𐐲. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑅𐐻𐑉𐐫𐑍 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐮𐑌𐑅𐐪𐑋𐑌𐐨𐐲 𐐲𐑌𐐼 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐐾𐐯𐐻 𐑊𐐰𐑀, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐑅𐑊𐐨𐐹 𐐿𐐶𐐪𐑊𐐲𐐻𐐨, 𐐲𐑌𐐼 𐑋𐐯𐑋𐐲𐑉𐐨; 𐐲𐑌𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐲𐑊𐐲𐑉𐐻𐑌𐐲𐑅.

• 𐐆𐑂𐐰𐑊𐐷𐐭𐐩𐑇𐐲𐑌 𐐲𐑂 𐑅𐑊𐐨𐐹, 𐐹𐐷𐐭𐐺𐐲𐑉𐐻𐐨 𐐲𐑌𐐼 𐑋𐐯𐑌𐐻𐐲𐑊 𐐸𐐯𐑊𐑃 𐐮𐑌 𐐽𐐮𐑊𐐼𐑉𐐲𐑌 𐐶𐐮𐑄 𐑊𐐫𐑍-𐐻𐐲𐑉𐑋 𐑋𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐑁𐐫𐑉 𐐿𐑉𐐪𐑌𐐮𐐿 𐐮𐐼𐐨𐐬𐐹𐐰𐑃𐐲𐐿 𐐽𐐴𐑊𐐼𐐸𐐳𐐼 𐑅𐑊𐐨𐐹 𐐪𐑌𐑅𐐯𐐻 𐐮𐑌𐑅𐐪𐑋𐑌𐐨𐐲.

• 𐐑𐑉𐐲𐑊𐐫𐑍𐐼-𐑉𐐨𐑊𐐨𐑅 𐑋𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌 𐐮𐑋𐐹𐑉𐐭𐑂𐑆 𐑅𐑊𐐨𐐹 𐐿𐐶𐐪𐑊𐐲𐐻𐐨 𐐲𐑌𐐼 𐑋𐐫𐑉𐑌𐐮𐑍 𐐲𐑊𐐲𐑉𐐻𐑌𐐲𐑅 𐐮𐑌 𐐮𐑌𐑅𐐪𐑋𐑌𐐨𐐲 𐐹𐐩𐑇𐐲𐑌𐐻𐑅 𐐩𐐾𐐼 55 𐐷𐐮𐑉𐑆 𐐲𐑌𐐼 𐐬𐑊𐐼𐐲𐑉 𐐲𐑌𐐼 𐐸𐐰𐑆 𐑌𐐬 𐐶𐐮𐑄𐐼𐑉𐐫𐐲𐑊 𐐮𐑁𐐯𐐿𐐻𐑅.

• 𐐜𐐲 𐐮𐑁𐐯𐐿𐐻 𐐲𐑂 𐐹𐑉𐐲𐑊𐐫𐑍𐐼-𐑉𐐨𐑊𐐨𐑅 𐑋𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌 𐐪𐑌 𐑅𐑊𐐨𐐹 𐑋𐐯𐑈𐐲𐑉𐑆 𐐲𐑌𐐼 psychomotor 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅 𐐮𐑌 𐐯𐑊𐐼𐐲𐑉𐑊𐐨 𐐹𐐩𐑇𐐲𐑌𐐻𐑅 𐐶𐐮𐑄 𐐮𐑌𐑅𐐪𐑋𐑌𐐨𐐲.

• Prophylaxis 𐐲𐑂 𐑋𐐴𐑀𐑉𐐩𐑌 𐐶𐐮𐑄 𐑋𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌: 𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊.

• 𐐣𐐯𐑊𐐲𐐻𐐬𐑌𐐮𐑌 𐑁𐐫𐑉 𐑄𐐲 𐐹𐑉𐐨𐑂𐐯𐑌𐑇𐐲𐑌 𐐲𐑌𐐼 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐐾𐐯𐐻 𐑊𐐰𐑀.

6) Rhodiola Rosea

Rhodiola Rosea 𐐮𐑆 𐐲 𐐹𐐲𐑉𐐯𐑌𐐨𐐲𐑊 𐑁𐑊𐐶𐐲𐑉𐐮𐑍 𐐹𐑊𐐰𐑌𐐻 𐑄𐐰𐐻 𐑀𐑉𐐬𐑆 𐐪𐑌 𐑅𐐨 𐐿𐑊𐐮𐑁𐑅 𐐲𐑌𐐼 𐑋𐐶𐑌𐐻𐐲𐑌𐑆 𐐮𐑌 𐐿𐐬𐑊𐐼 𐑉𐐨𐐾𐐲𐑌𐑆 𐐲𐑂 𐑄𐐲 𐐶𐐲𐑉𐑊𐐼. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑁𐐲𐐻𐐨𐑀, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑉𐐬𐐺𐐲𐑅𐐻 𐑉𐐨𐑅𐐲𐑉𐐽 𐐿𐐲𐑌𐐼𐐲𐐿𐐻𐐲𐐼 𐐶𐐮𐑄 𐑉𐐮𐐹𐐨𐐻𐐮𐐼 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐿𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐐻𐑉𐐴𐐲𐑊𐑆; 𐐲𐑌𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐐿𐐪𐑀𐑌𐐮𐑇𐐲𐑌 𐐲𐑌𐐼 𐑅𐐲𐐺𐐾𐐯𐐿𐐻𐐮𐑂 𐐶𐐯𐑊-𐐺𐐨𐐮𐑍, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌; 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐐹𐑉𐐪𐑅𐐯𐑅𐐮𐑍 𐐰𐐿𐐷𐐲𐑉𐐲𐑅𐐨; 𐐲𐑌𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑉𐐩𐐻 𐐲𐑂 𐐹𐐲𐑉𐑅𐐨𐑂𐐼 𐐮𐑀𐑆𐐲𐑉𐑇𐐲𐑌, 𐐲𐑌𐐼 𐑅𐐻𐑉𐐯𐑅.

• 𐐜𐐲 𐐮𐑁𐐯𐐿𐐻𐐮𐑂𐑌𐐲𐑅 𐐲𐑌𐐼 𐐯𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑂 Rhodiola rosea 𐐇𐑊.: 𐐲 𐑅𐐮𐑅𐐻𐐲𐑋𐐰𐐻𐐮𐐿 𐑉𐐨𐑂𐐷𐐭 𐐲𐑂 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐿𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐐻𐑉𐐴𐐲𐑊𐑆.

• 𐐛𐐯𐑉𐐲𐐹𐐷𐐭𐐻𐐮𐐿 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑌𐐼 𐑅𐐩𐑁𐐻𐐨 𐐲𐑂 Rhodiola rosea 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐔𐐲𐐺𐐲𐑊𐐷𐐭𐐯𐑅® 1375 𐐮𐑌 𐑅𐐲𐐺𐐾𐐮𐐿𐐻𐑅 𐐶𐐮𐑄 𐑊𐐴𐑁-𐑅𐐻𐑉𐐯𐑅 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆–𐑉𐐮𐑆𐐲𐑊𐐻𐑅 𐐲𐑂 𐐰𐑌 𐐬𐐹𐐲𐑌-𐑊𐐩𐐺𐐲𐑊 𐑅𐐻𐐲𐐼𐐨.

• 𐐊𐐿𐐷𐐭𐐻 Rhodiola rosea 𐐮𐑌𐐻𐐩𐐿 𐐿𐐰𐑌 𐐮𐑋𐐹𐑉𐐭𐑂 𐐯𐑌𐐼𐐲𐑉𐐲𐑌𐑅 𐐯𐐿𐑅𐐲𐑉𐑅𐐴𐑆 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅.

• 𐐊 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐹𐐴𐑊𐐲𐐻 𐑅𐐻𐐲𐐼𐐨 𐐲𐑂 𐑄𐐲 𐑅𐐻𐐮𐑋𐐷𐐲𐑊𐐩𐐻𐐮𐑍 𐐲𐑌𐐼 adaptogenic 𐐮𐑁𐐯𐐿𐐻 𐐲𐑂 Rhodiola rosea 𐐇𐑅𐐩𐐽𐐪𐑉-5 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐪𐑌 𐑄𐐲 𐑁𐐲𐐻𐐨𐑀 𐐲𐑂 𐑅𐐻𐐭𐐼𐐲𐑌𐐻𐑅 𐐿𐐪𐑆𐐼 𐐺𐐴 𐑅𐐻𐑉𐐯𐑅 𐐼𐐳𐑉𐐮𐑍 𐐰𐑌 𐐮𐑀𐑆𐐰𐑋𐐲𐑌𐐩𐑇𐐲𐑌 𐐹𐐮𐑉𐐨𐐲𐐼 𐐶𐐮𐑄 𐐲 𐑉𐐮𐐹𐐨𐐻𐐮𐐼 𐑊𐐬-𐐼𐐬𐑅 𐑉𐐯𐐾𐐲𐑋𐐲𐑌.

• 𐐊 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 𐐻𐐭 𐐼𐐮𐑁𐐲𐑉𐐲𐑌𐐻 𐐼𐐬𐑅𐐲𐑆 𐐲𐑂 𐐲 𐐇𐑅𐐩𐐽𐐪𐑉-5 Rhodiola rosea 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐑂𐐲𐑉𐑅𐐲𐑅 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐲𐑌𐐼 𐐿𐐲𐑌𐐻𐑉𐐬𐑊 𐐲𐑂 𐐿𐐲𐐹𐐰𐑅𐐲𐐻𐐨 𐑁𐐫𐑉 𐑋𐐯𐑌𐐻𐐲𐑊 𐐶𐐲𐑉𐐿.

• Rhodiola rosea 𐐮𐑌 𐑅𐐻𐑉𐐯𐑅 𐐮𐑌𐐼𐐭𐑅𐐻 𐑁𐐲𐐻𐐨𐑀–𐐲 𐐼𐐲𐐺𐐲𐑊 𐐺𐑊𐐴𐑌𐐼 𐐿𐑉𐐫𐑅-𐐬𐑂𐐲𐑉 𐑅𐐻𐐲𐐼𐐨 𐐲𐑂 𐐲 𐑅𐐻𐐰𐑌𐐼𐐲𐑉𐐼𐐴𐑆𐐼 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐇𐑅𐐩𐐽𐐪𐑉-5 𐐶𐐮𐑄 𐐲 𐑉𐐮𐐹𐐨𐐻𐐮𐐼 𐑊𐐬-𐐼𐐬𐑅 𐑉𐐯𐐾𐐲𐑋𐐲𐑌 𐐪𐑌 𐑄𐐲 𐑋𐐯𐑌𐐻𐐲𐑊 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅 𐐲𐑂 𐐸𐐯𐑊𐑃𐐨 𐑁𐐲𐑆𐐮𐑇𐐲𐑌𐑆 𐐼𐐳𐑉𐐮𐑍 𐑌𐐴𐐻 𐐼𐐭𐐻𐐨.

• 𐐜𐐲 𐐮𐑌𐑁𐑊𐐭𐐲𐑌𐑅 𐐲𐑂 adaptogens 𐐪𐑌 ultraweak biophoton 𐐮𐑋𐐮𐑇𐐲𐑌: 𐐲 𐐹𐐴𐑊𐐲𐐻-𐐮𐐿𐑅𐐹𐐯𐑉𐐲𐑋𐐲𐑌𐐻.

• Rhodiola Rosea 𐑁𐐫𐑉 𐐣𐐯𐑌𐐻𐐲𐑊 𐐲𐑌𐐼 𐐙𐐮𐑆𐐮𐐿𐐲𐑊 𐐙𐐲𐐻𐐨𐑀 𐐮𐑌 𐐤𐐲𐑉𐑅𐐮𐑍 𐐝𐐻𐐭𐐼𐐲𐑌𐐻𐑅: 𐐊 𐐡𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐗𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐓𐑉𐐴𐐲𐑊

• 𐐗𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 Rhodiola rosea 𐐇𐑊. 𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 𐐇𐑅𐐩𐐽𐐪𐑉-5 𐐮𐑌 𐑄𐐲 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐑋𐐴𐑊𐐼 𐐻𐐭 𐑋𐐪𐐼𐐲𐑉𐐲𐐻 𐐼𐐮𐐹𐑉𐐯𐑇𐐲𐑌.

7) Theanine

Theanine 𐐮𐑆 𐐰𐑌 𐐲𐑋𐐨𐑌𐐬 𐐰𐑅𐐲𐐼 𐐰𐑌𐐲𐑊𐐫𐑀 𐑁𐐶𐑌𐐼 𐐹𐑉𐐴𐑋𐐯𐑉𐐲𐑊𐐨 𐐮𐑌 𐐹𐐲𐑉𐐻𐐮𐐿𐐷𐐲𐑊𐐲𐑉 𐐹𐑊𐐰𐑌𐐻 𐐲𐑌𐐼 𐑁𐐲𐑍𐑀𐐲𐑊 𐑅𐐹𐐨𐑇𐐨𐑆. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐑉𐐨𐑊𐐰𐐿𐑅𐐩𐑇𐐲𐑌 (𐐷𐐭𐑈𐐲𐐶𐐲𐑊𐐨 𐐶𐐮𐑃𐐶𐐻 𐑅𐐲𐐼𐐩𐑇𐐲𐑌), 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼. 𐐆𐐻 𐑋𐐩 𐐫𐑊𐑅𐐬 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐐰𐑍𐑆𐐴𐐲𐐻𐐨, 𐐲𐑌𐐼 𐑅𐐮𐑋𐐹𐐻𐐲𐑋𐑆 𐐲𐑂 𐑅𐐿𐐮𐐻𐑅𐐲𐑁𐑉𐐨𐑌𐐨𐐲; 𐐲𐑌𐐼 𐐲 𐑋𐐴𐑌𐐲𐑉 𐐮𐑌𐐿𐑉𐐨𐑅 𐐻𐐭 𐑅𐑊𐐨𐐹 𐐿𐐶𐐪𐑊𐐲𐐻𐐨.

• 𐐜𐐲 𐐲𐐿𐐷𐐭𐐻 𐐮𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 𐐇𐑊-theanine 𐐮𐑌 𐐿𐐲𐑋𐐹𐐯𐑉𐐲𐑅𐐲𐑌 𐐶𐐮𐑄 alprazolam 𐐪𐑌 𐐰𐑌𐐻𐐮𐑅𐐲𐐹𐐲𐐻𐐫𐑉𐐨 𐐰𐑍𐑆𐐴𐐲𐐻𐐨 𐐮𐑌 𐐸𐐷𐐭𐑋𐐲𐑌𐑆

• 𐐆𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 𐐯𐑊-theanine 𐐪𐑌 𐐲𐐻𐐯𐑌𐑇𐐲𐑌 𐐲𐑌𐐼 𐑉𐐨𐐰𐐿𐑇𐐲𐑌 𐐻𐐴𐑋 𐑉𐐮𐑅𐐹𐐪𐑌𐑅

• 𐐆𐑁𐐯𐐿𐐻𐑅 𐐲𐑂 Theanine 𐐪𐑌 𐑄𐐲 𐐡𐐨𐑊𐐨𐑅 𐐲𐑂 𐐒𐑉𐐩𐑌 𐐈𐑊𐑁𐐲 𐐎𐐩𐑂 𐐮𐑌 𐐊𐐼𐐲𐑊𐐻 𐐣𐐩𐑊𐑆.

𐐤𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐑁𐐫𐑉 𐐣𐐴𐑀𐑉𐐩𐑌

𐐌𐑊 𐐫𐑊𐑅𐐬 𐑋𐐯𐑌𐑇𐐲𐑌 𐐲 𐐿𐐲𐐹𐐲𐑊 𐐲𐑂 𐐲𐑄𐐲𐑉 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅, 𐑌𐐪𐐻 𐑁𐐫𐑉 𐐾𐐯𐑌𐐲𐑉𐐲𐑊 𐐷𐐭𐑅, 𐐺𐐲𐐻 𐑅𐐹𐐲𐑅𐐮𐑁𐐮𐐿𐑊𐐨 𐑁𐐫𐑉 𐑄𐐬𐑆 𐑄𐐰𐐻 𐑋𐐩 𐑅𐐲𐑁𐐲𐑉 𐑁𐑉𐐲𐑋 𐑋𐐴𐑀𐑉𐐩𐑌 𐐸𐐯𐐼𐐩𐐿𐑅, 𐐶𐐮𐐽 𐐲𐑂 𐐿𐐫𐑉𐑅 𐑅𐐲𐑂𐐮𐑉𐑊𐐨 𐐼𐐮𐑀𐑉𐐩𐐼 𐐹𐑉𐐪𐐹𐐲𐑉 𐑋𐐯𐑌𐐻𐐲𐑊 𐐹𐐲𐑉𐑁𐐫𐑉𐑋𐐲𐑌𐑅. 𐐢𐐴𐐿 𐑄𐐲 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐑊𐐮𐑅𐐻𐐲𐐼 𐐲𐐺𐐲𐑂, 𐑄𐐨𐑆 𐐸𐐰𐑂 𐑅𐐪𐑊𐐲𐐼 𐑅𐐴𐐲𐑌𐐻𐐮𐑁𐐮𐐿 𐑉𐐨𐑅𐐲𐑉𐐽 𐑅𐐲𐐹𐐫𐑉𐐻𐐮𐑍 𐐮𐑁𐐯𐐿𐐻𐐮𐑂 𐐰𐐹𐑊𐐲𐐿𐐩𐑇𐐲𐑌𐑆. 𐐊𐑌𐐼 𐐫𐑊𐑄𐐬 𐐌 𐐸𐐰𐑂𐐲𐑌𐐻 𐐷𐐭𐑆𐐼 𐑄𐐯𐑋 𐑋𐐴𐑅𐐯𐑊𐑁, 𐑋𐐴 𐑅𐐲𐑌 𐐸𐐭 𐐸𐐰𐑆 𐑅𐐲𐑁𐐲𐑉𐐼 𐑁𐑉𐐲𐑋 𐑋𐐴𐑀𐑉𐐩𐑌 𐐸𐐯𐐼𐐩𐐿𐑅 𐐸𐐰𐑆 𐐷𐐭𐑆𐐼 𐑄𐐯𐑋 𐐶𐐮𐑄 𐑀𐐳𐐼 𐑉𐐮𐑆𐐲𐑊𐐻𐑅.

𐐙𐐨𐑂𐐲𐑉𐑁𐐷𐐭 𐐮𐑆 𐐲 𐐹𐐲𐑉𐐯𐑌𐐨𐐲𐑊 𐐲𐑉𐐺 𐑄𐐰𐐻 𐐶𐐪𐑆 𐑌𐐩𐐻𐐮𐑂 𐐻𐐭 𐐏𐐳𐑉𐐩𐑈𐐲 𐐲𐑌𐐼 𐐸𐐰𐑆 𐑅𐐹𐑉𐐯𐐼 𐐲𐑉𐐶𐑌𐐼 𐑄𐐲 𐐶𐐲𐑉𐑊𐐼. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑅𐐻𐑉𐐫𐑍 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑋𐐴𐑀𐑉𐐩𐑌, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑉𐐬𐐺𐐲𐑅𐐻 𐑉𐐨𐑅𐐲𐑉𐐽 𐐿𐐲𐑌𐐼𐐲𐐿𐐻𐐲𐐼 𐐶𐐮𐑄 𐑉𐐮𐐹𐐨𐐻𐐮𐐼 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐿𐑊𐐮𐑌𐐲𐐿𐐲𐑊 𐐻𐑉𐐴𐐲𐑊𐑆.

• 𐐇𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑌𐐼 𐑅𐐩𐑁𐐻𐐨 𐐲𐑂 6.25 𐐯𐑋𐑀𐐨 𐐻𐐨.𐐴.𐐼𐐨. 𐑁𐐨𐑂𐐲𐑉𐑁𐐷𐐭 𐐝𐐨𐐬2-𐐯𐐿𐑅𐐻𐑉𐐰𐐿𐐻 (𐐇𐑋𐐴𐐾𐐨-99) 𐐮𐑌 𐑋𐐴𐑀𐑉𐐩𐑌 𐐹𐑉𐐨𐑂𐐯𐑌𐑇𐐲𐑌–𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼, 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, multicentre, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐑅𐐻𐐲𐐼𐐨.

• 𐐜𐐲 𐐯𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑌𐐼 𐑅𐐩𐑁𐐻𐐨 𐐲𐑂 Tanacetum parthenium (𐑁𐐨𐑂𐐲𐑉𐑁𐐷𐐭) 𐐮𐑌 𐑋𐐴𐑀𐑉𐐩𐑌 prophylaxis–𐐲 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, multicentre, 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐼𐐬𐑅-𐑉𐐮𐑅𐐹𐐪𐑌𐑅 𐑅𐐻𐐲𐐼𐐨.

• 𐐇𐑁𐐮𐐿𐐰𐑅𐐨 𐐲𐑂 𐑁𐐨𐑂𐐲𐑉𐑁𐐷𐐭 𐐰𐑆 𐐹𐑉𐐪𐑁𐐮𐑊𐐰𐐿𐐻𐐮𐐿 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐲𐑂 𐑋𐐴𐑀𐑉𐐩𐑌.

• Randomised 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊 𐐲𐑂 𐑁𐐨𐑂𐐲𐑉𐑁𐐷𐐭 𐐮𐑌 𐑋𐐴𐑀𐑉𐐩𐑌 𐐹𐑉𐐨𐑂𐐯𐑌𐑇𐐲𐑌.

𐐚𐐴𐐻𐐲𐑋𐐲𐑌 𐐒𐐨2 𐐮𐑆 𐑁𐐶𐑌𐐼 𐐮𐑌 𐑋𐐮𐑊𐐿, 𐐽𐐨𐑆, 𐑊𐐨𐑁𐐨 𐑂𐐯𐐾𐐻𐐲𐐺𐐲𐑊𐑆, 𐑊𐐮𐑂𐐲𐑉, 𐐿𐐮𐐼𐑌𐐨𐑆, 𐑊𐐯𐑀𐐷𐐭𐑋𐑆, 𐐷𐐨𐑅𐐻, 𐑋𐐲𐑇𐑉𐐭𐑋𐑆, 𐐲𐑌𐐼 𐐪𐑊𐑋𐐲𐑌𐐼𐑆. 𐐝𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐐩𐑇𐐲𐑌 𐑋𐐩 𐐹𐑉𐐲𐑂𐐴𐐼 𐐲 𐑌𐐬𐐻𐐲𐐺𐐲𐑊 𐐼𐐮𐐿𐑉𐐨𐑅 𐐻𐐭 𐑋𐐴𐑀𐑉𐐩𐑌, 𐐲𐐿𐐫𐑉𐐼𐐮𐑍 𐐻𐐭 𐑋𐐲𐑊𐐻𐐲𐐹𐐲𐑊 𐑅𐐻𐐲𐐼𐐨𐑆 𐐶𐐯𐑉 𐐰𐐻 𐑊𐐨𐑅𐐻 𐐻𐐭 𐐪𐑉 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼 𐐲𐑌𐐼 𐐹𐑊𐐲𐑅𐐨𐐺𐐬 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼.

• 𐐐𐐴-𐐼𐐬𐑅 riboflavin 𐐻𐑉𐐨𐐻𐑋𐐲𐑌𐐻 𐐮𐑆 𐐯𐑁𐐲𐐿𐐩𐑇𐐲𐑅 𐐮𐑌 𐑋𐐴𐑀𐑉𐐩𐑌 prophylaxis: 𐐰𐑌 𐐬𐐹𐐲𐑌 𐑅𐐻𐐲𐐼𐐨 𐐮𐑌 𐐲 𐐻𐐲𐑉𐑇𐐲𐑉𐐨 𐐿𐐯𐑉 𐑅𐐯𐑌𐐻𐐲𐑉.
• 𐐊 𐐿𐐪𐑋𐐺𐐲𐑌𐐩𐑇𐐲𐑌 𐐲𐑂 riboflavin, 𐑋𐐰𐑀𐑌𐐨𐑆𐐨𐐲𐑋, 𐐲𐑌𐐼 𐑁𐐨𐑂𐐲𐑉𐑁𐐷𐐭 𐑁𐐫𐑉 𐑋𐐴𐑀𐑉𐐩𐑌 prophylaxis: 𐐲 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐻𐑉𐐴𐐲𐑊.
• 𐐆𐑁𐐯𐐿𐐻𐐮𐑂𐑌𐐲𐑅 𐐲𐑂 𐐸𐐴-𐐼𐐬𐑅 riboflavin 𐐮𐑌 𐑋𐐴𐑀𐑉𐐩𐑌 prophylaxis. 𐐊 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼 𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊.
• Riboflavin prophylaxis 𐐮𐑌 𐐹𐐨𐐼𐐨𐐰𐐻𐑉𐐮𐐿 𐐲𐑌𐐼 𐐰𐐼𐐲𐑊𐐯𐑅𐐲𐑌𐐻 𐑋𐐴𐑀𐑉𐐩𐑌.
• 𐐐𐐴-𐐼𐐬𐑅 riboflavin 𐑁𐐫𐑉 𐑋𐐴𐑀𐑉𐐩𐑌 prophylaxis 𐐮𐑌 𐐽𐐮𐑊𐐼𐑉𐐲𐑌: 𐐲 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐑉𐐰𐑌𐐼𐐲𐑋𐐴𐑆𐐼, 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼 𐐻𐑉𐐴𐐲𐑊.
• 𐐣𐐴𐐻𐐲𐐿𐐪𐑌𐐼𐑉𐐨𐐲𐑊 𐐔𐐨𐐯𐑌𐐩 haplogroups 𐐮𐑌𐑁𐑊𐐭𐐲𐑌𐑅 𐑄𐐲 𐑃𐐯𐑉𐐲𐐹𐐷𐐭𐐻𐐮𐐿 𐑉𐐮𐑅𐐹𐐪𐑌𐑅 𐐻𐐭 riboflavin 𐐮𐑌 migraineurs.
• 𐐣𐐨𐐼𐐨𐐲𐑋-𐐼𐐬𐑅 riboflavin 𐐰𐑆 𐐲 𐐹𐑉𐐪𐑁𐐮𐑊𐐰𐐿𐐻𐐮𐐿 𐐩𐐾𐐲𐑌𐐻 𐐮𐑌 𐐽𐐮𐑊𐐼𐑉𐐲𐑌 𐐶𐐮𐑄 𐑋𐐴𐑀𐑉𐐩𐑌: 𐐲 𐐹𐑉𐐮𐑊𐐮𐑋𐐲𐑌𐐯𐑉𐐨 𐐹𐑊𐐲𐑅𐐨𐐺𐐬-𐐿𐐲𐑌𐐻𐑉𐐬𐑊𐐼, randomised, 𐐼𐐲𐐺𐐲𐑊-𐐺𐑊𐐴𐑌𐐼, 𐐿𐑉𐐫𐑅-𐐬𐑂𐐲𐑉 𐐻𐑉𐐴𐐲𐑊.

𐐗𐐲𐑋𐐺𐐴𐑌𐐼 𐐤𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿

𐐒𐐮𐐿𐐫𐑆 𐐮𐐻 𐐿𐐰𐑌 𐐺𐐨 𐐻𐐨𐐼𐐨𐐲𐑅 𐐲𐑌𐐼 𐐮𐐿𐑅𐐹𐐯𐑌𐑅𐐮𐑂 𐐻𐐭 𐑁𐐴𐑌𐐼, 𐐹𐐲𐑉𐐽𐐲𐑅, 𐐲𐑌𐐼 𐑅𐐶𐐪𐑊𐐬 𐐫𐑊 𐐲𐑂 𐑄𐐨𐑆 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐑅𐐯𐐹𐐲𐑉𐐲𐐻𐑊𐐨, 𐐌 𐐶𐐲𐑉𐐿𐐻 𐐶𐐮𐑄 𐐲 𐐿𐐯𐑋𐐮𐑅𐐻 𐐻𐐭 𐐿𐐪𐑋𐐺𐐴𐑌 𐑅𐐲𐑋 𐐲𐑂 𐑄𐐯𐑋. 𐐌 𐐫𐑊𐑅𐐬 𐐬𐐹𐐲𐑌𐐼 𐐰𐑌 𐐫𐑌𐑊𐐴𐑌 𐑅𐐻𐐫𐑉 𐐻𐐭 𐑅𐐯𐑊 𐑄𐐲 𐐿𐐲𐑋𐐺𐐴𐑌𐐼 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿, 𐐛𐑉𐐴𐑂𐐲𐑅 𐐗𐑊𐐯𐑉𐐲𐐻𐐨, 𐐰𐐻 𐐲 𐐹𐑉𐐴𐑅 𐑅𐐮𐑀𐑌𐐮𐑁𐐮𐐿𐐲𐑌𐐻𐑊𐐨 𐐺𐐮𐑊𐐬 𐑄𐐰𐐻 𐐲𐑂 𐐹𐐲𐑉𐐽𐐲𐑅𐐮𐑍 𐐿𐐲𐑋𐐹𐐬𐑌𐐲𐑌𐐻𐑅 𐑅𐐯𐐹𐐲𐑉𐐲𐐻𐑊𐐨. 𐐈𐑆 𐐲𐑂 6 𐐁𐐹𐑉𐐲𐑊 2016, 𐐗𐑊𐐯𐑉𐐲𐐻𐐨 𐐮𐑆 𐑌𐐶 𐐲𐑂𐐩𐑊𐐲𐐺𐐲𐑊 𐑁𐐫𐑉 𐐹𐐲𐑉𐐽𐐲𐑅.

𐐙𐐴𐑌𐐲𐑊𐐨, 𐐹𐑊𐐨𐑆 𐑉𐐮𐑋𐐯𐑋𐐺𐐲𐑉 𐐻𐐭 𐐿𐐲𐑌𐑅𐐲𐑊𐐻 𐐲 𐑋𐐯𐐼𐐲𐐿𐐲𐑊 𐐹𐑉𐐲𐑁𐐯𐑇𐐲𐑌𐐲𐑊 𐐺𐐮𐑁𐐫𐑉 𐐲𐑌𐐼 𐐼𐐳𐑉𐐮𐑍 𐐷𐐫𐑉 𐐷𐐭𐑅 𐐲𐑂 𐑄𐐨𐑆 𐐫𐑉 𐐯𐑌𐐨 𐐲𐑄𐐲𐑉 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐐫𐑉 𐑅𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻𐑅. 𐐊𐑌𐐼 𐐼𐐭 𐐷𐐫𐑉 𐐬𐑌 𐑉𐐨𐑅𐐲𐑉𐐽 𐐻𐐭 𐑂𐐯𐑉𐐲𐑁𐐴 𐐰𐐼𐑂𐐴𐑅 𐐷𐐭 𐑉𐐲𐑅𐐨𐑂 𐑁𐑉𐐲𐑋 𐑄𐐯𐑋, 𐑁𐑉𐐲𐑋 𐑋𐐨, 𐐫𐑉 𐑁𐑉𐐲𐑋 𐐯𐑌𐐨𐐶𐐲𐑌 𐐯𐑊𐑅.

𐐆𐑁 𐐷𐐭 𐑊𐐴𐐿 𐑄𐐨𐑆 𐑃𐐫𐐻𐑅, 𐐷𐐭 𐑋𐐴𐐻 𐐫𐑊𐑅𐐬 𐑊𐐴𐐿 “𐐢𐐮𐑍𐐿𐐲𐑌 𐐗𐐰𐑌𐐲𐑌𐑆 𐐝𐐻𐐰𐐿 𐐲𐑂 50 𐐤𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿𐑅 𐐲𐑌𐐼 𐐖𐐯𐑉𐐬𐐹𐑉𐐲𐐻𐐯𐐿𐐻𐐲𐑉𐑆.” 𐐆𐐻𐑅 𐐲 𐑌𐐭𐐲𐑉 𐐪𐑉𐐻𐐲𐐿𐐲𐑊, 𐐹𐐲𐐺𐑊𐐮𐑇𐐻 𐐪𐑌 𐑄𐐲 𐐛𐑉𐐴𐑂𐐲𐑅 𐐶𐐯𐐺𐑅𐐴𐐻, 𐐮𐑌 𐐶𐐮𐐽 𐐌 𐑇𐐯𐑉 𐐲 𐑊𐐮𐑅𐐻 𐐲𐑂 𐑋𐐴 𐑌𐐬𐐲𐐻𐑉𐐪𐐹𐐮𐐿 𐐲𐑌𐐼 𐐾𐐯𐑉𐐬𐐹𐑉𐐲𐐻𐐯𐐿𐐻𐐲𐑉 𐑅𐐲𐐹𐑊𐐲𐑋𐐲𐑌𐐻 𐑉𐐯𐐾𐐲𐑋𐐲𐑌 𐑅𐐯𐑂𐑉𐐲𐑊 𐐷𐐮𐑉𐑆 𐑊𐐩𐐻𐐲𐑉.

𐐆𐑌𐑅𐐻𐐲𐐻𐐭𐐻 𐑁𐐫𐑉 𐐇𐑃𐐮𐐿𐑅 𐐲𐑌𐐼 𐐆𐑋𐐲𐑉𐐾𐐮𐑍 𐐓𐐯𐐿𐑌𐐪𐑊𐐲𐐾𐐨𐑆 𐑊𐐩𐐻𐐲𐑉 𐑉𐐨𐐹𐐲𐐺𐑊𐐮𐑇𐐻 𐑄𐐮𐑅 𐐪𐑉𐐻𐐲𐐿𐐲𐑊.